The antibiotics dilemma: Why we're running out of drugs to treat the superbugs
by manubrium
It's the $40 billion drug market that no company wants a part of. As resistance to antibiotics allows long-treatable diseases to once again become killers, pharmaceutical companies are sacking their antibiotic researchers. Keri Phillips reports.